Isomorphic Labs, Alphabet’s AI-driven drug discovery arm, is on the verge of launching the first human trials of medicines designed entirely by artificial intelligence. The outcome could redefine the future of pharmaceutical innovation and patient care.
MoneyOval is a global media company delivering insights at the intersection of finance, business, technology, and innovation.
From boardroom decisions to blockchain trends, MoneyOval provides clarity to the forces driving today’s economic landscape.